Engineers Gate Manager LP Solid Biosciences Inc. Transaction History

Engineers Gate Manager LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $4,899 - $14,129	-11,395 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.74 - $1.79 $8,432 - $20,397	11,395 New	11,395 $14,000
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $136,808 - $215,992	-39,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $210,504 - $420,224	39,200 New	39,200 $217,000
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.08 $32,604 - $49,714	-16,141 Closed	0 $0

Q2 2020 Aug 17, 2020	BUY	$2.1 - $3.42 $33,896 - $55,202	16,141 New	16,141 $47,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $11.64 $101,534 - $272,946	-23,449 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $107,865 - $237,538	23,449 New	23,449 $135,000
Q2 2018 Aug 03, 2018	SELL	$7.33 - $43.15 $171,067 - $1.01 Million	-23,338 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$7.19 - $33.17 $167,800 - $774,121	23,338 New	23,338 $175,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $42.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.